Association of Genetic Variants With Moyamoya Disease in 13 000 Individuals A Meta-Analysis
Association of Genetic Variants With Moyamoya Disease in 13 000 Individuals A Meta-Analysis
复制标题
DOI:
10.1161/strokeaha.120.029527
复制
发表时间:
2020-06-01
期刊:
影响因子:
8.3
通讯作者:
Liu, Wanyang
中科院分区:
文献类型:
--
作者:
Wang, Xiaotong;Wang, Yue;Liu, Wanyang
Background and Purpose-A growing body of evidence indicates genetic components play critical roles in moyamoya disease (MMD). Firm conclusions from studies of this disease have been stymied by small sample sizes and a lack of replicative results. This meta-analysis was conducted to determine whether these genetic polymorphisms are associated with MMD.Methods-PubMed, Google Scholar, Embase, Wanfang, Web of Science, and China National Knowledge Infrastructure databases were used to identify potentially relevant studies published until January 2020. The Review Manager 5.2 and Stata 15.0 software programs were used to perform the statistical analysis. Heterogeneity was assessed using the Cochran Q test and quantified using the I-2 test.Results-Four thousand seven hundred eleven MMD cases and 8704 controls in 24 studies were included, evaluating 7 polymorphisms in 6 genes. The fixed-effect odds ratios (95% CI) in allelic model of MMP-2 rs243865 were 0.60 (0.41-0.88) (P=0.008). In the country-based subgroup analysis, the fixed-effect odds ratios (95% CI) of RNF213 rs112735431 in allelic model were China, 39.74 (26.63-59.31), Japan, 74.65 (42.79-130.24) and Korea, 50.04 (28.83-86.88; all P